Table 1.
Progression for 2560 AREDS AMD (Category 1–3 at Baseline) patients over 10.3 years (Yu et al. [4])
AMD category | n | Progressed to next stage | No progression |
---|---|---|---|
1 | 713 | 494 (69 %) | 219 (31 %) |
2 | 1190 | 376 (32 %) | 814 (68 %) |
3 | 1527 | 578 (8 %) | 949 (62 %) |
3–4 | 280 | 280 (18 %) | NA |
3–5 | 298 | 298 (20 %) | NA |
Includes patients treated and not treated with AREDS supplements [5]
AREDS Age-Related Eye Disease Study, AMD age-related macular degeneration, NA not applicable